Search CDMOs

• CMC Analytical Development
• API Synthesis & Manufacturing
• Biologics Development & Manufacturing

Lonza is the world's leading CDMO, founded in Switzerland in 1897, serving the healthcare industry with integrated offerings for contract development and manufacturing of therapies across multiple modalities.

• Biologics (Other)
• Peptide
• Small Molecule

Integrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries.

• Peptide
• Small Molecule

Canadian CRO and CDMO specializing in polymer synthesis, peptide characterization, and advanced analytical services for drug delivery and pharmaceutical development. FDA-registered and ISO 9001:2015 certified, serving North American pharmaceutical and biotech companies.

• AAV / Viral Vector Platform
• Gene Therapy

Viralgen is a CDMO specializing exclusively in cGMP AAV gene therapy manufacturing, with the world's largest dedicated AAV production capacity and a 100% success rate for IND/IMPD dossiers across 50+ gene therapy customers.

• AAV Manufacturing
• CMC Analytical Development
• Biologics Development & Manufacturing

ProBioGen AG is a CDMO offering cell line development, process development, GMP manufacturing and analytical services for proteins, antibodies, viral vectors and vaccines. It also provides technology platforms for biopharmaceutical manufacturing.

• AAV / Viral Vector Platform
• Biologics (Other)
• Vaccine

Leading CRO/CDMO provider specializing in viral vectors, proteins, and vaccines with proprietary AAV manufacturing technology and cGMP-grade facilities operational since October 2023.

• CMC Analytical Development
• Cartridge Filling
• CMC Regulatory Submission Support

US-based aseptic fill-finish CDMO specializing in parenteral biologics, peptides, and small molecules from development through commercial supply, with formulation, analytical, stability testing, and vial/syringe/cartridge filling capabilities.

• CMC Analytical Development
• Cell Therapy Manufacturing
• CMC Regulatory Submission Support

Leading cell therapy CDMO delivering GMP manufacturing, analytics, and CMC strategy from early development through commercial launch across purpose-built U.S. facilities.

• CMC Analytical Development
• Biologics Development & Manufacturing
• Cell-Line Development

U.S.-based CDMO offering end-to-end biomanufacturing services for antibodies, recombinant proteins, vaccines, and other biologics modalities, with dedicated microbial and mammalian facilities and in-house cell line development capabilities.

• CMC Analytical Development
• Controlled Substance Manufacturing
• Formulation Development

Independent, family-owned CDMO specializing in oral solids, semi-solids, and controlled-substance manufacturing with 475,000 sq ft cGMP facility in Bristol, TN; over 80 products commercialized.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

India's largest CDMO with 15+ state-of-the-art facilities and 30% domestic market share, manufacturing 4,100+ formulations across tablets, capsules, injectables, APIs, and specialty dosage forms under WHO-GMP, USFDA, EU-GMP, and TGA compliance.

• CMC Analytical Development
• CMC Regulatory Submission Support
• Sterile Fill-Finish & Aseptic Manufacturing

Ascendia is a specialty CDMO providing formulation development, analytical services, and GMP manufacturing for small molecules and biologics from pre-formulation through commercialization, with proprietary nanotechnologies including LipidSol, EmulSol, AmorSol, and NanoSol.

• ADC (Antibody-Drug Conjugate) Manufacturing
• CMC Analytical Development
• API Synthesis & Manufacturing

Ardena is an integrated CDMO and bioanalytical CRO specializing in advanced drug product development, nanomedicine, and bioanalysis for complex molecules including poorly soluble compounds, highly potent APIs, and controlled substances.

• CMC Analytical Development
• CMC Regulatory Submission Support
• Formulation Development

Glatt Pharmaceutical Services is a CDMO specializing in complex oral solid dosage forms, multiparticulate systems (pellets, micropellets, granules), and advanced drug delivery solutions including controlled release, solubility enhancement, and taste masking from early development through commercial manufacturing.

• Allogeneic Cell Therapy Manufacturing
• CMC Analytical Development
• Autologous Cell Therapy Manufacturing

Cell-Easy is a CDMO specializing in development and GMP manufacturing of cell therapies, with expertise across T cells, NK cells, MSCs, and iPSCs. The company has manufactured over 1,000 clinical doses and supports 50+ development programs from process optimization through regulatory compliance.

• CMC Analytical Development
• Cell-Line Development
• Cell Therapy Manufacturing

Cell therapy CDMO offering end-to-end development, GMP manufacturing, and regulatory support from preclinical through commercial scale, with specialized expertise in T cells, NK cells, MSCs, iPSCs, and other cell modalities.

• CMC Analytical Development
• CMC Regulatory Submission Support
• Sterile Fill-Finish & Aseptic Manufacturing

Germany-based CDMO specializing in nanoparticle formulation, process development, GMP manufacturing, and aseptic fill-finish for nanomedicines and advanced drug delivery products.

• ADC (Antibody-Drug Conjugate) Manufacturing
• Biologics Development & Manufacturing
• Monoclonal Antibody (mAb) Manufacturing

AsymBio is a CDMO providing one-stop biopharmaceutical manufacturing solutions for conjugated drugs, antibodies, and recombinant proteins, with capabilities spanning early-stage research through commercial-scale production.